Global Orphan Drugs Market: Industry Analysis & Outlook (2018-2022)
Table of Contents
1. Overview
1.1 Orphan Disease
1.2 Orphan Drugs
2. Global Orphan Drugs Market
2.1 Global Orphan Drugs Market by Value
2.2 Global Orphan Drugs Market Forecast by Value
2.3 Global Orphan Drugs Market by Product
2.3.1 Global Revlimid Drug Revenue Forecast
2.3.2 Global Rituxan Drug Revenue Forecast
2.3.3 Global Opvido Drug Revenue Forecast
2.4 Global Orphan Drugs Market by Therapy
2.4.1 Global Oncology Therapy Market Forecast by Value
2.4.2 Global Blood Therapy Market Forecast by Value
2.4.3 Global Central Nervous System Therapy Market Forecast by Value
3. Regional Market Analysis
3.1 The Americas
3.1.1 The US Orphan Drugs Spending Forecast
3.1.2 The US Orphan Drug by Designation Volume
3.1.3 The US Orphan Drug Average & Median Cost per Patient
3.1.4 The US Orphan Drug Average & Median Cost per Patient Forecast
3.1.5 Canada Orphan Drugs Spending
3.1.6 Canada Orphan Drugs Spending Forecast
3.2 Europe
3.2.1 Europe Orphan Drugs Market Forecast by Value
3.2.2 Europe Orphan Drugs Market by Product
3.2.3 Europe Orphan Drug by Designation Volume
3.3 Asia
3.3.1 Japan Orphan Drug by Designation Volume
3.3.2 India Orphan Drugs Market Forecast by Value
4. Market Dynamics
4.1 Growth Drivers
4.1.1 Prolonged Orphan Drug Market Exclusivity
4.1.2 Increasing Sales of Prescription Drugs
4.1.3 Attractive Orphan Drug Policies
4.1.4 Rising Healthcare Expenditure
4.1.5 Improving Economic Condition
4.1.6 Increasing Prevalence of Chronic Diseases
4.2 Key Trends & Development
4.2.1 Rise in Orphan Drug Approvals
4.2.2 Accelerating Pipeline Sales of Orphan Drugs
4.2.3 Development of Drug Therapies
4.2.4 Increasing Scope of Gene Therapy
4.3 Challenges
4.3.1 High Costs
4.3.2 Lack of Diagnostic Systems and Trained Professionals
4.3.3 Insufficient Disease Information and Research Participants
4.3.4 Rising Competition from Generic Industry
5. Competitive Landscape
5.1 Global Market
5.1.1 Revenue and Market Cap Comparison
5.1.2 Global Orphan Drugs Market Share by Company
5.1.3 Global Oncology Orphan Drugs Market Share by Company
5.2 The US
5.2.1 The US Top 10 Orphan Drugs Sales by Company
5.3 Europe
5.3.1 Europe Orphan Drugs Market Share by Company
6. Company Profiles
6.1 Novartis International AG
6.1.1 Business Overview
6.1.2 Financial Overview
6.1.3 Business Strategies
6.2 Roche Holding AG
6.2.1 Business Overview
6.2.2 Financial Overview
6.2.3 Business Strategies
6.3 Bristol-Myers Squibb
6.3.1 Business Overview
6.3.2 Financial Overview
6.3.3 Business Strategies
6.4 Celgene Corporation
6.4.1 Business Overview
6.4.2 Financial Overview
6.4.3 Business Strategies
List of Tables
Orphan Disease Prevalence in Different Nations
Orphan Drug Market Exclusivity
Orphan Drug Policies
Prices and Prevalence of Some Orphan Drugs in the US (2017)
Key Players - Revenue & Market Cap Comparison (2017)
The US Top 10 Orphan Drugs Sales by Company (2017)
Novartis Agreements (2018)
Novartis Major Product Approvals (2018)
Roche Agreements (2017/2018)
Roche Product Approvals (2018)
Bristol-Myers Squibb Agreements (2018)
Celgene R&D Expenditure (2015-2017)
List of Charts
Types of Orphan Drugs
Orphan Drug Development
Global Orphan Drugs Market by Value (2013-2017)
Global Orphan Drugs Market Forecast by Value (2018-2022)
Global Orphan Drugs Market by Product (2017)
Global Revlimid Drug Revenue Forecast (2017-2022)
Global Rituxan Drug Revenue Forecast (2017-2022)
Global Opvido Drug Revenue Forecast (2017-2022)
Global Orphan Drugs Market by Therapy (2017)
Global Oncology Therapy Market Forecast by Value (2017-2022)
Global Blood Therapy Market Forecast by Value (2017-2022)
Global Central Nervous System Therapy Market Forecast by Value (2017-2022)
The US Orphan Drugs Spending Forecast (2017-2022)
The US Orphan Drug by Designation Volume (2013-2017)
The US Orphan Drug Average & Median Cost per Patient (2013-2017)
The US Orphan Drug Average & Median Cost per Patient Forecast (2018-2022)
Canada Orphan Drugs Spending (2013-2017)
Canada Orphan Drugs Spending Forecast (2018-2022)
Europe Orphan Drugs Market Forecast by Value (2017-2022)
Europe Orphan Drugs Market by Product (2017)
Europe Orphan Drug by Designation Volume (2013-2017)
Japan Orphan Drug by Designation Volume (2013-2017)
India Orphan Drugs Market Forecast by Value (2017-2022)
Global Prescription Drugs Sales (2013-2022)
Global Healthcare Expenditure (2013-2017)
Global GDP Per Capita (2013-2017)
Global Cancer Prevalence (2012-2030E)
The US FDA Orphan Drug Approvals (2010-2017)
The US Orphan Novel Drug Approvals (2010-2017)
Global Worldwide Orphan Drug Pipeline Sales (2018-2024)
Projection of Top 10 Orphan Drugs in Development (phase III/filed) by NPV* (2018)
Global Orphan Drugs Market Share by Company (2017/2024)
Global Oncology Orphan Drugs Market Share by Company (2017/2024)
Europe Orphan Drugs Market Share by Company (2017)
Novartis Sales by Segment (2017)
Novartis Net Sales and Net Income (2013-2017)
Roche Sales by Segments (2017)
Roche Sales and Net Income (2013-2017)
Bristol-Myers Squibb Revenue by Region (2017)
Bristol-Myers Squibb Total Revenue and Net Earnings (2013-2017)
Bristol-Myers Squibb R&D Expenditure (2015-2017)
Celgene Revenue by Region (2017)
Celgene Total Revenue and Net Income (2013-2017)
Global Antioxidant Vitamins Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 100
The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
Global Clavulanate Potassium Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 86
The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030.
North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
Global Amoxicillin Sodium Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 84
The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030.
North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
Global Melatonin Supplements Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 106
The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 93
The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
Global Sleeping Pills Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 94
The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
Global Zinc Oral Drops Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 85
The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
Global Zinc Drops Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 85
The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
Global Anti-Infectives Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 78
The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs